CHEST Physician
-
Artificial intelligence in lung cancer management
As artificial intelligence continues to integrate into clinical practice, the future of lung cancer management is shifting toward precision-driven, data-informed strategies and risk prediction models.
-
CHEST announces critical care education and certification exam for NPs, PAs
CHEST announced the launch of an educational program and formal certification exam for NPs and PAs in critical care.
-
Exploring the evolving landscape in combination therapies for EGFR-mutated advanced NSCLC
Susan Scott, MD, discussed the findings from the MARIPOSA and FLAURA2 trials and the next steps to identify who may benefit from which regimen.
-
FDA proposal would eliminate addicting power of cigarettes, other combustible tobacco products
While the rule could reduce smoking rates, Sven-Eric Jordt, PhD, said clinicians must remember that low-nicotine cigarettes still expose those who smoke to carcinogens.
-
Intersection of American Heart Month and Black History Month offers chance to highlight disparities in care
Marcus St. John, MD, said health system-wide checklists can combat implicit bias and help ensure all patients receive appropriate care.
-
Key points of the 2025 Medicare Physician Fee Schedule
CMS has released the 2025 Medicare Physician Fee Schedule rule. Read a summary of key points that clinicians need to know about.
-
The Medicare conversion factor: What is it and why is it punishing physicians?
This year’s final rule from CMS provided the long-expected but unwelcome news of a 2.8% cut in the 2025 Medicare conversion factor.
-
Managing central airway obstruction
New guidelines on central airway obstruction standardize diagnosis and management recommendations, emphasizing therapeutic bronchoscopy, rigid bronchoscopy, and multidisciplinary care.
-
The rising use of ketamine for airway management
Ketamine’s unique properties make it valuable for critical care treatments including airway management, sedation, and analgesia.
-
Top reads from the CHEST journal portfolio – February 2025
Read commentary of studies on oronasal CPAP for OSA, the impact of pirfenidone on IPF, and extracorporeal membrane oxygenation for high-risk PE.